Cargando…

Early Oxygen Treatment Measurements Can Predict COVID-19 Mortality: A Preliminary Study

Halting the rapid clinical deterioration, marked by arterial hypoxemia, is among the greatest challenges clinicians face when treating COVID-19 patients in hospitals. While it is clear that oxygen measures and treatment procedures describe a patient’s clinical condition at a given time point, the po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levi, Yosi, Yamin, Dan, Brandes, Tomer, Shmueli, Erez, Patalon, Tal, Peretz, Asaf, Gazit, Sivan, Nahir, Barak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222284/ https://www.ncbi.nlm.nih.gov/pubmed/35742198 http://dx.doi.org/10.3390/healthcare10061146

Ejemplares similares

Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
por: Yechezkel, Matan, et al.
Publicado: (2023)

Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
por: Mofaz, Merav, et al.
Publicado: (2022)

A multi-layer model for the early detection of COVID-19
por: Shmueli, Erez, et al.
Publicado: (2021)

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
por: Gazit, Sivan, et al.
Publicado: (2022)

Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
por: Patalon, Tal, et al.
Publicado: (2023)

Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022)

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
por: Mizrahi, Barak, et al.
Publicado: (2021)

Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation
por: Gazit, Sivan, et al.
Publicado: (2023)

Evaluating red blood cell distribution width from community blood tests as a predictor of hospitalization and mortality in adults with SARS-CoV-2: a cohort study
por: Banon, Tamar, et al.
Publicado: (2021)

Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study
por: Fallach, Noga, et al.
Publicado: (2022)

Higher sensitivity monitoring of reactions to COVID-19 vaccination using smartwatches
por: Guan, Grace, et al.
Publicado: (2022)

Immunosuppression as a Hub for SARS-CoV-2 Mutational Drift
por: Shapira, Guy, et al.
Publicado: (2023)

SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021
por: Patalon, Tal, et al.
Publicado: (2022)

A Data-Driven Strategy for Identifying Individuals Resistant to SARS-CoV-2 Virus under In-Household Exposure
por: Hen Gabzi, Roni, et al.
Publicado: (2022)

Mpox Patient Journey in Israel
por: Patalon, Tal, et al.
Publicado: (2023)

Mpox Infection in a Developed Country: A Case Report
por: Patalon, Tal, et al.
Publicado: (2022)

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022)

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998-2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS.
por: Tadmor, Tamar, et al.
Publicado: (2023)

Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia
por: Tadmor, Tamar, et al.
Publicado: (2023)

Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
por: Grupel, Daniel, et al.
Publicado: (2021)

P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)
por: Levy, Ilana, et al.
Publicado: (2023)

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization
por: Chodick, Gabriel, et al.
Publicado: (2021)

An Outbreak of Parvovirus B19 in Israel
por: Patalon, Tal, et al.
Publicado: (2023)

Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting
por: Ben-Tov, Amir, et al.
Publicado: (2022)

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign
por: Ben-Tov, Amir, et al.
Publicado: (2023)

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
por: Prunas, Ottavia, et al.
Publicado: (2021)

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
por: Prunas, Ottavia, et al.
Publicado: (2022)

Waning of SARS-CoV-2 booster viral-load reduction effectiveness
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
por: Adler, Limor, et al.
Publicado: (2022)

State-based targeted vaccination
por: Lev, Tomer, et al.
Publicado: (2021)

Cost-Effectiveness of Pertussis Vaccination Schedule in Israel
por: Langsam, Dean, et al.
Publicado: (2021)

Total proteome turbidity assay for tracking global protein aggregation in the natural cellular environment
por: Shmueli, Merav D., et al.
Publicado: (2017)

SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since Diagnosis
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

Real-time sensing of war’s effects on wellbeing with smartphones and smartwatches
por: Mofaz, Merav, et al.
Publicado: (2023)

Age-Dependent Biomarkers for Prediction of In-Hospital Mortality in COVID-19 Patients
por: Feigin, Eugene, et al.
Publicado: (2022)

Author Correction: The role of mPFC and MTL neurons in human choice under goal-conflict
por: Gazit, Tomer, et al.
Publicado: (2020)

The role of mPFC and MTL neurons in human choice under goal-conflict
por: Gazit, Tomer, et al.
Publicado: (2020)

Differential effects of COVID-19 lockdowns on well-being: interaction between age, gender and chronotype
por: Oved, Shay, et al.
Publicado: (2021)

Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine
por: Gepner, Yftach, et al.
Publicado: (2022)

BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign
por: Ben-Tov, Amir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rbvpimuc4dk0lofuj75358j0a2